Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases

BACKGROUND: Bedaquiline was recently introduced into World Health Organization (WHO)-recommended regimens for treatment of drug resistant tuberculosis. There is limited data on the long-term safety of bedaquiline. Because bedaquiline prolongs the QT interval, there are concerns regarding cardiovascu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Infect Dis
Huvudupphovsmän: Jones, Jackie, Mudaly, Vanessa, Voget, Jacqueline, Naledi, Tracey, Maartens, Gary, Cohen, Karen
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6585062/
https://ncbi.nlm.nih.gov/pubmed/31221100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-4197-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk